Jafron Biomedical Co.,Ltd.’s Net Profit Rose 18.2% in First Quarter of 2022

Jafron Biomedical Co.,Ltd. (健帆生物科技集团股份有限公司) (300529.SZ) reported a net profit of 334.4 million yuan in the first quarter of 2022, up 18.2% year-on-year.

Meanwhile, the company posted 697.4 million yuan in revenue, up 20.5% year-on-year.

At the end of the reporting period, it had 5.1 billion yuan in total assets and 1.4 billion yuan in total liabilities, with a liability-to-asset ratio of 27%.

This article was automatically produced by Caixin Automation on April 17, 2023.

Download our app to receive breaking news alerts and read the news on the go.

Follow the Chinese markets in real time with Caixin Global’s new stock database.